DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Amgen - 2 Eli Lilly - 2 Bob Bradway - 2 Bradway - 1 Jay Bradner - 1 autoinjector - 1 Novo Nordisk's Wegovy - 1 Eli Lilly's Zepbound - 1
Top related locs:
North Carolina Novo Nordisk's U.S Indiana Ireland Germany U.S San Francisco GLP
Top related orgs:
Novo Nordisk - 2 Novo Nordisk's - 1 Jefferies - 1 MariTide - 1 Nordisk - 1 Abbott Labs - 1 Covid - 1 Novartis - 1

Search resuls for: "Bob Bradway"


2 mentions found


☆ Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
  + stars: | 2024-05-03 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +4 min
That fueled investor concerns about new competition in the rapidly growing weight loss drug industry, sending shares of the current obesity players, Novo Nordisk and Eli Lilly , lower on Friday. Eli Lilly shares dropped nearly 3%, while Novo Nordisk's U.S.-traded shares fell more than 1%. Still, investors were pleased with Eli Lilly on Tuesday after the company assured them it can overcome ongoing supply constraints for its popular drugs. Eli Lilly hiked its full-year guidance in part due to optimism around increased production of Zepbound, its diabetes injection Mounjaro and similar drugs for the rest of the year. That signals Novo Nordisk is struggling to meet demand for the treatment.
Persons: Amgen, Eli Lilly, Bob Bradway, Bradway, Jay Bradner, autoinjector, Novo Nordisk's Wegovy, Eli Lilly's Zepbound, William Blair, Matt Phipps, Michael Yee, Amgen's Bradway, Karsten Munk Knudsen Organizations: Novo Nordisk, Novo Nordisk's, Jefferies, MariTide, Nordisk Locations: Novo Nordisk's U.S, North Carolina, Indiana, Ireland, Germany, U.S
☆ 4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry
  + stars: | 2024-01-15 | by ( Jim Cramer | ) www.cnbc.com   time to read: +12 min
We will go over them – but first, let me talk about what I learned at last week's JPMorgan Health Care Conference that I attended in San Francisco, and what it means to your portfolio. We know health care has a lot of angles too it. The previous CEO Roz Brewer was from Starbucks and struggled with the role that Walgreens plays in health care. You have to be following the transformation of Bristol-Myers, which is opening its wallet to buy a host of drug companies, including anti-psychotic firm Karuna. Health care is the way to go.
Persons: Regeneron, Pfizer, Eli Lilly, Dave Ricks, Lilly, donanemab, Lilly's, Zepbound, it's, Abbott, It's, Roche, Merck, Myers, ABT, Robert Ford, Tim Wentworth, He's, Roz Brewer, Wentworth, he'll, Brewer wasn't, Bob Bradway, Amgen, Vas Narasimhan, Sandoz, Karuna, Medtronic, Hugo, Morgan Stanley, Wells, Covid, Cramer's, Jim Cramer, Jim, Las Vegas Brendan Smialowski Organizations: Abbott Labs, Covid, Novartis, Amgen, Walgreens Boots Alliance, JPMorgan Health Care Conference, Humana, Drug Administration, Novo Nordisk, Dickinson Co, Bristol, Myers Squibb, Pfizer, Department, WBA, Walgreens, Starbucks, -, pharma, Merck, Keytruda, Horizon Therapeutics, Federal Trade Commission, Myers, BD, CVS Health, JPMorgan, Cramer's Charitable, CNBC, Consumer, AFP, Getty Locations: San Francisco, GLP, North Carolina, Europe, Cencora, Amgen, West, Bristol, Target, Las Vegas
0 next >>
Total: 2